An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...
The FDA has cleared PRF Technologies’ Investigational New Drug application for OcuRing-K, enabling a Phase 2 U.S. trial in late 2026 to evaluate sustained-release pain and inflammation control after ...
SHREVEPORT, La. - After cataract surgery, it's normal to have some swelling of the cornea that should resolve after a couple of weeks. However, if that swelling doesn't clear, it could be a sign of ...
Milestone supports advancement of PRF’s drop-less ocular drug-delivery platform into next-stage U.S. clinical development for post-cataract pain and inflammationTEL AVIV, Israel, April 28, 2026 (GLOBE ...